US Patent Issued to CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE, YAOPHARMA on June 2 for "Crystalline form of fluvatinib or fluvatinib methanesulfonate and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,861, issued on June 2, was assigned to CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE Co. LTD (Chongqing, China) and YAOPHARMA Co. LTD. (Chongqing, China).

"Crystalline form of fluvatinib or fluvatinib methanesulfonate and preparation method therefor" was invented by Shuai He (Chongqing, China), Yang Zhang (Jiangsu, China), Qiang Liu (Chongqing, China), Zhengxia Chen (Jiangsu, China), Meibi Dai (Jiangsu, China), Bin Fan (Chongqing, China) and Peiyu Xie (Chongqing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed in the present invention is a crystalline form of fluvatinib or fluvatinib methanesulfonate, and a preparation method therefor. T...